Small Cell Lung Carcinoma
104
22
32
35
Key Insights
Highlights
Success Rate
69% trial completion
Published Results
17 trials with published results (16%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
15.4%
16 terminated out of 104 trials
68.6%
-18.0% vs benchmark
9%
9 trials in Phase 3/4
49%
17 of 35 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 35 completed trials
Clinical Trials (104)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer
MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer
Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer.
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
A Study of LY4175408 in Participants With Advanced Cancer
A French Real-life Study: EvaluatioN of durvALumab Utilization and Effectiveness for First Line Extensive Stage Small Cell Lung Cancer.
An Exploratory Study of Lurbinectedin With Radiotherapy in SCLC With Single-lesion Progression After First Course Treatment
A Study of Hospital-at-Home for People Receiving Tarlatamab
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain